More tools:Markets·Screener·Research·Chat

Surrozen, Inc. Common (SRZN) Financial Statements

Surrozen, Inc. Common
SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
FIGI BBG00XY94SB2
XNAS · usd
20.68▼ 2.08 (-9.14%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close22.76
Day's Range20.63 – 23.18
52-Week Range11.25 – 35.00
Volume202.1K
Avg Volume254.5K
Share Statistics
Shares Outstanding
Employees44
ExchangeXNAS
Listed2021-08-12
Share count as of August 4, 2026
Loading Income Statement…
Key questions about Surrozen, Inc. Common (SRZN)
What is Surrozen, Inc. Common's Market Cap?
Surrozen, Inc. Common's Market Cap is $243.1M, based on as-reported figures from SEC (XBRL) filings.
What is Surrozen, Inc. Common's Enterprise Value?
Surrozen, Inc. Common's Enterprise Value is $141.0M, based on as-reported figures from SEC (XBRL) filings.
What is Surrozen, Inc. Common's Price / Sales?
Surrozen, Inc. Common's Price / Sales is 21.1×, based on as-reported figures from SEC (XBRL) filings.
What is Surrozen, Inc. Common's EV / Revenue?
Surrozen, Inc. Common's EV / Revenue is 12.3×, based on as-reported figures from SEC (XBRL) filings.
What is Surrozen, Inc. Common's EV / EBITDA?
Surrozen, Inc. Common's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Surrozen, Inc. Common's Revenue (TTM)?
Surrozen, Inc. Common's Revenue (TTM) is $11.5M, based on as-reported figures from SEC (XBRL) filings.
What is Surrozen, Inc. Common's Net Income (TTM)?
Surrozen, Inc. Common's Net Income (TTM) is -$332.1M, based on as-reported figures from SEC (XBRL) filings.
What is Surrozen, Inc. Common's EBITDA?
Surrozen, Inc. Common's EBITDA is -$44.1M, based on as-reported figures from SEC (XBRL) filings.
What is Surrozen, Inc. Common's Diluted EPS (TTM)?
Surrozen, Inc. Common's Diluted EPS (TTM) is -28.26, based on as-reported figures from SEC (XBRL) filings.
What is Surrozen, Inc. Common's EBITDA Margin?
Surrozen, Inc. Common's EBITDA Margin is -383.4%, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Research service revenue - related party—
Total revenue
YoY growth+408.6%+408.6%-19.4%-90.2%
Operating expenses:
Research and development
General and administrative
Total operating expenses
% of revenue307.4%309.1%2493.8%1207.3%
Loss from operations
% of revenue-207.4%-209.1%-2393.8%-1107.3%
Interest income
Loss on amendment and cancellation of warrants
Loss on execution of the 2025 PIPE
Gain (loss) on change in fair value of tranche liability
Gain on settlement of tranche liability
Other income (expense), net (Note 3)
Net income (loss) and comprehensive income (loss)
% of revenue1003.5%-2550.1%-34689.2%-7288.2%
Net income (loss) available to (attributable to) common stockholders, basic——
Net income (loss) available to (attributable to) common stockholders, Diluted——
Net income (loss) per share available to (attributable to) common stockholders, Basic—
Net income (loss) per share available to (attributable to) common stockholders, Diluted—